Search hospitals > California > Loma Linda
Loma Linda University Medical Center
Claim this profileLoma Linda, California 92354
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Leukemia
Conducts research for Tumors
Conducts research for Lymphoma
449 reported clinical trials
33 medical researchers
Summary
Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Cancer, Recurrence, Leukemia, Tumors, Lymphoma and other specialties. Loma Linda University Medical Center is involved with conducting 449 clinical trials across 924 conditions. There are 33 research doctors associated with this hospital, such as Albert Kheradpour, Hamid R. Mirshahidi, Mark E. Reeves, and Hisham Abdel-Azim, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Recurrence
Global LeaderStage IV
Stage III
Stage II
Top PIs
Albert KheradpourLoma Linda University Medical Center7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
54 reported clinical trials
104 drugs studied
Hamid R. MirshahidiLoma Linda University Medical Center5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
18 drugs studied
Mark E. ReevesVeterans Affairs Loma Linda Healthcare System4 years of reported clinical research
Studies Cancer
Studies Tumors
5 reported clinical trials
9 drugs studied
Hisham Abdel-Azim, MDChildren's Hospital of Los Angeles5 years of reported clinical research
Studies Quality of Life
Studies Leukemia
4 reported clinical trials
5 drugs studied
Clinical Trials running at Loma Linda University Medical Center
Non-Small Cell Lung Cancer
Lung Cancer
Brain Tumor
Osteosarcoma
Germ Cell Tumors
Astrocytoma
Glioblastoma
Langerhans Cell Histiocytosis
Recurrence
Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Ramucirumab + Pembrolizumab vs Chemotherapy
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Loma Linda University Medical Center?
Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Cancer, Recurrence, Leukemia, Tumors, Lymphoma and other specialties. Loma Linda University Medical Center is involved with conducting 449 clinical trials across 924 conditions. There are 33 research doctors associated with this hospital, such as Albert Kheradpour, Hamid R. Mirshahidi, Mark E. Reeves, and Hisham Abdel-Azim, MD.
Where is Loma Linda University Medical Center located?
**Loma Linda University Medical Center**
- **Address:** 11234 Anderson St, Loma Linda, CA 92354
- **Directions:** Take the I-10 E to exit 62 for Anderson St in Loma Linda, then turn left onto Anderson St.
**Loma Linda University Medical Center-Murrieta**
- **Address:** 28062 Baxter Rd, Murrieta, CA 92563
- **Directions:** Head to 28062 Baxter Rd, Murrieta via I-15 N and CA-79 S.
Who should I call to ask about financial aid or insurance network?
**Loma Linda University Medical Center Financial Assistance and Insurance Inquiries:**
- For financial assistance, including policies and application processes, contact the billing department at **909-651-4177**. They assist uninsured or underinsured patients with hospital bill concerns.
- For insurance-related questions, including billing, patient balances, and claim submissions, call **909-651-4177**. Note: Most physicians and independent healthcare providers will issue separate bills.
What insurance does Loma Linda University Medical Center accept?
Loma Linda University Medical Center accepts a broad spectrum of insurance plans, such as popular HMOs and PPOs, Inland Empire Health Plan (IEHP), Medi-Cal, and Medicare. They are also part of the Blue Shield HMO and PPO networks, ensuring access to their medical centers, urgent cares, and primary care providers. It's advised to verify coverage with your insurance company directly.
What awards or recognition has Loma Linda University Medical Center received?
Loma Linda University Medical Center is renowned for its groundbreaking medical achievements and has been awarded $85 million in extramural awards for research in the last fiscal year. The center is celebrated for milestones including the first infant heart transplant, pioneering the use of a proton accelerator for cancer treatment, and inventing a nerve block technique in dentistry. It boasts prestigious accolades such as Comprehensive Stroke Center Certification, Quality Accredited Cancer Program by the American College of Surgeons, and Magnet Recognition for excellence in nursing.